(BKYI) BIO-Key International - Ratings and Ratios
Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US09060C3097
BKYI: Biometric, Fingerprint, Identification, Security, Software, Solutions
BIO-key International, Inc. (NASDAQ:BKYI) specializes in biometric identification technologies and enterprise-grade identity access management (IAM) solutions. The company serves a diverse range of sectors, including corporate, government, and education, both domestically and internationally. Its flagship product, BIO-key PortalGuard, is a cloud-based IAM platform designed to integrate seamlessly with SaaS applications, on-premises systems, and cloud services. PortalGuard IDaaS extends these capabilities, offering a customer-controlled, neutral-by-design identity platform. These solutions enhance security for workforces, student populations, and partner networks, enabling collaboration while minimizing risks. The company also offers BIO-key VST and WEB-key products, as well as Civil and Large-Scale ID Infrastructure solutions, which leverage fingerprint-based biometric technology for advanced identification needs. Under the SideSwipe, EcoID, and SidePass brands, BIO-key provides finger scanners tailored for both enterprise and consumer markets. Originally founded in 1993 as SAC Technologies, the company rebranded as BIO-key International, Inc. in 2002 and is headquartered in Holmdel, New Jersey.
3-Month Forecast: Based on technical and fundamental data, BIO-key International, Inc. (BKYI) is expected to experience continued volatility. The stock is currently trading at $1.22, with a 20-day average volume of 111,098 shares. The SMA 20 ($1.10) and SMA 50 ($1.37) indicate recent fluctuations, with the stock price oscillating above and below these levels. The SMA 200 ($1.30) suggests a potential resistance level. The ATR of $0.22 signals moderate price movement expectations. Fundamentally, the companys market cap of $3.25M and P/S ratio of 0.54 reflect its micro-cap status and potential sensitivity to market sentiment. Over the next three months, BKYI may face headwinds due to its high P/B ratio (29.40) and lack of profitability (P/E: 0.00). Technical support near $1.00 and resistance around $1.50 are key levels to monitor.
Additional Sources for BKYI Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
BKYI Stock Overview
Market Cap in USD | 3m |
Sector | Industrials |
Industry | Security & Protection Services |
GiC Sub-Industry | Systems Software |
IPO / Inception | 1997-02-14 |
BKYI Stock Ratings
Growth Rating | -87.5 |
Fundamental | -5.05 |
Dividend Rating | 0.0 |
Rel. Strength | -50.2 |
Analysts | 4/5 |
Fair Price Momentum | 0.31 USD |
Fair Price DCF | - |
BKYI Dividends
No Dividends PaidBKYI Growth Ratios
Growth Correlation 3m | -87.7% |
Growth Correlation 12m | -62.5% |
Growth Correlation 5y | -98.7% |
CAGR 5y | -64.00% |
CAGR/Max DD 5y | -0.64 |
Sharpe Ratio 12m | -1.17 |
Alpha | -57.72 |
Beta | 0.989 |
Volatility | 79.82% |
Current Volume | 1390.8k |
Average Volume 20d | 132.3k |
As of April 26, 2025, the stock is trading at USD 0.79 with a total of 1,390,814 shares traded.
Over the past week, the price has changed by +15.87%, over one month by -27.12%, over three months by -46.68% and over the past year by -47.04%.
Neither. Based on ValueRay Fundamental Analyses, BIO-Key International is currently (April 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of -5.05 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of BKYI as of April 2025 is 0.31. This means that BKYI is currently overvalued and has a potential downside of -60.76%.
BIO-Key International has received a consensus analysts rating of 4.00. Therefor, it is recommend to buy BKYI.
- Strong Buy: 0
- Buy: 1
- Hold: 0
- Sell: 0
- Strong Sell: 0
According to ValueRays Forecast Model, BKYI BIO-Key International will be worth about 0.4 in April 2026. The stock is currently trading at 0.79. This means that the stock has a potential downside of -55.7%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 3 | 279.7% |
Analysts Target Price | 3 | 279.7% |
ValueRay Target Price | 0.4 | -55.7% |